Global /Australia /Healthcare /Biotechnology /HCT
chevron_leftBack
Holista Colltech Ltd. logo

Holista Colltech Ltd.

HCT
ASX: HCT Delayed
0.0690AUD 0%
0.0486 USD
As of 14 June 2026, Holista Colltech Ltd. has a market cap of $17.84M USD, ranking #37876 globally and #1122 in Australia. It ranks #3379 in the Healthcare sector, and #663 in the Biotechnology industry.
Global Rank
37876
Country Rank
1122
Sector Rank
3379
Industry Rank
663
Key Stats
Market Cap
$17.84MUSD
25.38M AUD
Enterprise Value
$16.39MUSD
23.27M AUD
Revenue (TTM)
$4.07MUSD
5.79M AUD
EBITDA (TTM)
$221.97KUSD
315.07K AUD
Net Income (TTM)
-$667.01KUSD
-948.92K AUD
EBITDA Margin
5.4%
Profit Margin
-16%
PS Ratio
4.4
PB Ratio
-60.7
EV/EBITDA
72.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Leong Loong open_in_new
Employees
58
Website
holistaco.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
0% 9.5% 9.5% -13% -14% 60%

News

Loading...

Markets

Exchange Ticker Price
Australian Securities Exchange
MIC: XASX
PRIMARY
HCT
Holista CollTech Ltd
ISIN: AU000000HCT4
Shares Out.:
367.834M1
TV:
SA:
YF:
GF:
BA:
HCT
MS:
0.0690 AUD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Holista Colltech Ltd.

Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. Further, it provides GI LiTE, a premix glycemic index reducer, and LOGIC, a sweetening solution alternative for health-conscious consumers. The company also offers biogenic particles, low fat chips, and water soluble technology. Holista Colltech Limited is based in Subiaco, Australia.

Similar Companies

Industry: Biotechnology (Australia)
Name
Market Cap diff.
PE
CSL
$42.36B
60.27B AUD
237K%
29.3
$3.58B
5.09B AUD
20K%
-
MSB
$2.02B
2.88B AUD
11K%
-
PNV
$490.46M
697.75M AUD
3K%
71.8
$141.64M
694%
-
IMM
$65.26M
92.84M AUD
266%
-
Industry: Biotechnology (Global)
Name
Market Cap diff.
PE
AMGN
$182.42B
1M%
23.9
GILD
$159.92B
896K%
19.0
ARGX
$47.84B
41.39B EUR
268K%
39.9
$44.84B
68.19T KRW
251K%
35.5
LONN
$42.3B
33.71B CHF
237K%
37.2
068270
$28.11B
42.76T KRW
157K%
43.8
chevron_leftBack